Specifically, CD44 was found in a perinecrotic, hypoxic niche with HIF-1α- and HIF-2α-positive glioma cells, as well as a perivascular, highly oxygenated niche with pseudo-hypoxic, HIF-2α-positive, stem-like cells43. This evidence concerns the gene CD44 and central nervous system cancer.